CIK 0001600620 · Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981231763
- Phone
- 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $546,373
- in 2 filings
Net −$546,373. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Donley Matthew Maxwell Chief Operating Officer | Shares withheld for taxes | −40,761 | $14.21 | $579K | 680,299 |
| 2026-03-02 | Greenleaf Peter Chief Executive Officer | Shares withheld for taxes | −100,890 | $14.21 | $1.4M | 1,840,379 |
| 2026-03-02 | Robertson Stephen P. EVP, General Counsel | Shares withheld for taxes | −36,525 | $14.21 | $519K | 505,861 |
| 2026-03-02 | TANG KEVIN Director | Purchase | +83,561 | $14.33 | $1.2M | 11,929,500 |
| 2026-03-02 | TANG KEVIN Director | Purchase | +115,792 | $14.21 | $1.6M | 12,045,292 |
| 2026-02-27 | Miller Joseph M Chief Financial Officer | Grant or award | +57,229 | 613,932 | ||
| 2026-02-27 | Miller Joseph M Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +95,700 | 95,700 | ||
| 2026-02-27 | Donley Matthew Maxwell Chief Operating Officer | Grant or award | +58,160 | 721,060 | ||
| 2026-02-27 | Donley Matthew Maxwell Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +97,256 | 97,256 | ||
| 2026-02-27 | Greenleaf Peter Chief Executive Officer | Grant or award | +196,403 | 1,941,269 | ||
| 2026-02-27 | Greenleaf Peter Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +328,424 | 328,424 | ||
| 2026-02-27 | Keenan Greg SVP, Chief Medical Officer | Grant or award | +40,586 | 162,518 | ||
| 2026-02-27 | Keenan Greg SVP, Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +67,870 | 67,870 | ||
| 2026-02-27 | Robertson Stephen P. EVP, General Counsel | Grant or award | +59,090 | 542,386 | ||
| 2026-02-27 | Robertson Stephen P. EVP, General Counsel | Grant or award · Employee Stock Option (right to buy) | +98,813 | 98,813 | ||
| 2026-02-27 | TANG KEVIN Director | Purchase | +300,000 | $13.90 | $4.2M | 11,629,500 |
| 2026-02-27 | TANG KEVIN Director | Purchase | +214,839 | $14.12 | $3.0M | 11,844,339 |
| 2026-02-27 | TANG KEVIN Director | Purchase | +1,600 | $14.38 | $23K | 11,845,939 |
| 2026-02-20 | Robertson Stephen P. EVP, General Counsel | Shares withheld for taxes | −34,638 | $14.40 | $499K | 483,296 |
| 2026-02-20 | Miller Joseph M Chief Financial Officer | Shares withheld for taxes | −32,424 | $14.40 | $467K | 556,703 |
Page 2 of 10 · 197 trades